Protalix BioTherapeutics
PLX
#8929
Rank
NZ$0.39 B
Marketcap
NZ$4.89
Share price
2.00%
Change (1 day)
40.69%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): NZ$0.36

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.37. In 2025 the company made an earnings per share (EPS) of NZ-$0.14 a decrease over its 2024 EPS that were of NZ$0.06974.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.36-360.38%
2025NZ-$0.14-300%
2024NZ$0.06974-66.67%
2023NZ$0.21-138.71%
2022NZ-$0.54-50%
2021NZ-$1.08181.82%
2020NZ-$0.38-82.11%
2019NZ-$2.14-31.67%
2018NZ-$3.14-72.31%
2017NZ-$11.33124.14%
2016NZ-$5.06-147.54%
2015NZ$10.63-290.62%
2014NZ-$5.586.67%
2013NZ-$5.23130.77%
2012NZ-$2.27-69.77%
2011NZ-$7.5019.44%
2010NZ-$6.28-12.2%
2009NZ-$7.1536.67%
2008NZ-$5.23-37.5%
2007NZ-$8.3750%
2006NZ-$5.583.23%
2005NZ-$5.40138.46%
2004NZ-$2.27-74%
2003NZ-$8.72-0%
2002NZ-$8.72-50%
2001NZ-$17.43233.33%
2000NZ-$5.23-84.21%
1999NZ-$33.12-24%
1998NZ-$43.58-600%
1997NZ$8.72-16.67%
1996NZ$10.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.28 523.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$11.70 3,095.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.19-152.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.39 552.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel